Skip to main content
Contact Us
Subscribe
E-Edition
72°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIOVF
Recent news which mentions BIOVF
Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants
October 16, 2023
Tickers
AZN
BIOVF
PFE
SNY
Tags
BIOVF
SNY
News
From
Benzinga
Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon
June 09, 2023
Tickers
AZN
AZNCF
BIOVF
SNY
Tags
SNY
Briefs
News
From
Benzinga
Apellis Pharma Flunks On Primary, Secondary Endpoints In Amyotrophic Lateral Sclerosis Study
May 25, 2023
Tickers
APLS
BIOVF
Tags
Health Care
Biotech
Equities
From
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
May 11, 2023
Tickers
ABNB
BIOVF
CTIC
PACW
Tags
PLTR
Stocks To Watch
Small Cap
From
Benzinga
Why Shares of CTI BioPharma Are Soaring Wednesday
May 10, 2023
Tickers
BIOVF
CTIC
Tags
Market News
CTIC
Recent Press Releases
From
Motley Fool
European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
May 10, 2023
Tickers
BIOVF
CTIC
Tags
Market News
Benzinga
Trading Ideas
From
Benzinga
Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year
March 21, 2023
Tickers
BIOVF
SELB
Tags
BIOVF
General
Briefs
From
Benzinga
Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug
November 10, 2022
Tickers
BIOVF
VERU
Tags
Trading Ideas
Sabizabulin
BIOVF
From
Benzinga
Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
November 04, 2022
Tickers
AZN
AZNCF
BIOVF
SNY
Tags
AZNCF
Market News
Benzinga
From
Benzinga
Sanofi's Hemophilia Candidate Goes Under Priority FDA Review
August 30, 2022
Tickers
BIOVF
SNY
Tags
General
SNY
News
From
Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After
July 11, 2022
Tickers
BIOVF
CANF
IBB
INVA
Tags
SNY
LJPC
General
From
Benzinga
SOBI-Sanofi Partnered Hemophilia Therapy Shows Superior Bleed Protection Than Prior Prophylaxis
July 11, 2022
Tickers
BIOVF
SNY
Tags
Health Care
General
Biotech
From
Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
July 08, 2022
Tickers
ADCT
ANNX
ATHX
BIOVF
Tags
Large Cap
RVLP
Market News
From
Benzinga
ADC Therapeutics, Sobi Ink European Licensing Pact For Lymphoma Drug
July 08, 2022
Tickers
ADCT
BIOVF
Tags
BIOVF
General
News
From
Benzinga
Sanofi-SOBI Hemophilia Candidate Aces Late-Stage Study In Pretreated Patients
March 09, 2022
Tickers
BIOVF
SNY
Tags
Movers
News
Briefs
From
Benzinga
Apellis - Sobi's Pegcetacoplan Wins European Approval For Rare Blood Disorder
December 15, 2021
Tickers
APLS
BIOVF
Tags
Health Care
General
Briefs
From
Benzinga
AstraZeneca Blocks SOBI's $8B Buyout, Advent Withdraws The Bid - Report
December 03, 2021
Tickers
AZN
AZNCF
BIOVF
Tags
AZNCF
Market News
Benzinga
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.